About
Rahko was a UK quantum machine learning company applying quantum algorithms to drug discovery and pharmaceutical research. Founded in 2018 as a UCL spinout, Rahko developed quantum-enhanced methods for molecular simulation and drug-target interaction modelling. Rahko was acquired by ORCA Computing in 2025, bringing its quantum ML capabilities, including work with pharmaceutical companies and quantum chemistry algorithms, into ORCA's photonic quantum computing portfolio. The acquisition strengthened ORCA's drug discovery and materials science application layer.
Quantum Specifications
| Quantum Focus | software |
Key People
NB
Nathan Brown
Co-founder
LC
Leo Canas
Co-founder
Backed By
Lakestar
Lightspeed Venture Partners
Quantum Coast Capital
Type One Ventures
Trumpf Venture
Gic Government Of Singapore Investment Corporation
Hercules Capital
Inven Capital
Frequently Asked Questions
Rahko was a UK quantum machine learning company applying quantum algorithms to drug discovery and pharmaceutical research. Founded in 2018 as a UCL spinout, Rahko developed quantum-enhanced methods for molecular simulation and drug-target interaction modelling. Rahko was acquired by ORCA Computing in 2025, bringing its quantum ML capabilities, including work with pharmaceutical companies and quantum chemistry algorithms, into ORCA's photonic quantum computing portfolio. The acquisition streng...
Rahko is headquartered in London, United Kingdom.
Rahko was founded in 2018.
Rahko operates in the following sectors: quantum software.